content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001708269</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001818794</issuerCik>
        <issuerName>Dyne Therapeutics, Inc.</issuerName>
        <secFileNumber>001-39509</secFileNumber>
        <issuerAddress>
          <com:street1>1560 TRAPELO ROAD</com:street1>
          <com:city>WALTHAM</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02451</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>(781) 786-8230</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Atlas Venture Fund XI, L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Shareholder</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Merrill</name>
          <address>
            <com:street1>555 California Street</com:street1>
            <com:street2>Floor 18</com:street2>
            <com:city>San Francisco</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>94104</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>300000</noOfUnitsSold>
        <aggregateMarketValue>6723000.00</aggregateMarketValue>
        <noOfUnitsOutstanding>61375598</noOfUnitsOutstanding>
        <approxSaleDate>02/23/2024</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>04/26/2019</acquiredDate>
        <natureOfAcquisitionTransaction>Private Placement</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>300000</amountOfSecuritiesAcquired>
        <paymentDate>04/26/2019</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Atlas Venture Fund XI, L.P.</name>
          <address>
            <com:street1>300 Technology Square</com:street1>
            <com:street2>Suite 8</com:street2>
            <com:city>Cambridge</com:city>
            <com:stateOrCountry>MA</com:stateOrCountry>
            <com:zipCode>02139</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <saleDate>02/15/2024</saleDate>
        <amountOfSecuritiesSold>177906</amountOfSecuritiesSold>
        <grossProceeds>4249848.59</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Atlas Venture Fund XI, L.P.</name>
          <address>
            <com:street1>300 Technology Square</com:street1>
            <com:street2>Suite 8</com:street2>
            <com:city>Cambridge</com:city>
            <com:stateOrCountry>MA</com:stateOrCountry>
            <com:zipCode>02139</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <saleDate>02/16/2024</saleDate>
        <amountOfSecuritiesSold>162707</amountOfSecuritiesSold>
        <grossProceeds>3764512.97</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Atlas Venture Fund XI, L.P.</name>
          <address>
            <com:street1>300 Technology Square</com:street1>
            <com:street2>Suite 8</com:street2>
            <com:city>Cambridge</com:city>
            <com:stateOrCountry>MA</com:stateOrCountry>
            <com:zipCode>02139</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <saleDate>02/20/2024</saleDate>
        <amountOfSecuritiesSold>169539</amountOfSecuritiesSold>
        <grossProceeds>3852242.10</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Atlas Venture Fund XI, L.P.</name>
          <address>
            <com:street1>300 Technology Square</com:street1>
            <com:street2>Suite 8</com:street2>
            <com:city>Cambridge</com:city>
            <com:stateOrCountry>MA</com:stateOrCountry>
            <com:zipCode>02139</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <saleDate>02/21/2024</saleDate>
        <amountOfSecuritiesSold>184501</amountOfSecuritiesSold>
        <grossProceeds>4165304.91</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Atlas Venture Fund XI, L.P.</name>
          <address>
            <com:street1>300 Technology Square</com:street1>
            <com:street2>Suite 8</com:street2>
            <com:city>Cambridge</com:city>
            <com:stateOrCountry>MA</com:stateOrCountry>
            <com:zipCode>02139</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <saleDate>02/22/2024</saleDate>
        <amountOfSecuritiesSold>119360</amountOfSecuritiesSold>
        <grossProceeds>2704646.63</grossProceeds>
      </securitiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>02/23/2024</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>01/10/2024</planAdoptionDate>
        </planAdoptionDates>
        <signature>Ommer Chohan</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 6102}]
text: 144
  0001708269
  XXXXXXXX
  LIVE
  0001818794
  Dyne Therapeutics, Inc.
  001-39509
  1560 TRAPELO ROAD
  WALTHAM
  MA
  02451
  (781) 786-8230
  Atlas Venture Fund XI, L.P.
  Shareholder
  Common
  Merrill
  555 California Street
  Floor 18
  San Francisco
  CA
  94104
  300000
  6723000.00
  61375598
  02/23/2024
  NASDAQ
  Common
  04/26/2019
  Private Placement
  Issuer
  N
  300000
  04/26/2019
  Cash
  N
  Atlas Venture Fund XI, L.P.
  300 Technology Square
  Suite 8
  Cambridge
  MA
  02139
  Common
  02/15/2024
  177906
  4249848.59
  Atlas Venture Fund XI, L.P.
  300 Technology Square
  Suite 8
  Cambridge
  MA
  02139
  Common
  02/16/2024
  162707
  3764512.97
  Atlas Venture Fund XI, L.P.
  300 Technology Square
  Suite 8
  Cambridge
  MA
  02139
  Common
  02/20/2024
  169539
  3852242.10
  Atlas Venture Fund XI, L.P.
  300 Technology Square
  Suite 8
  Cambridge
  MA
  02139
  Common
  02/21/2024
  184501
  4165304.91
  Atlas Venture Fund XI, L.P.
  300 Technology Square
  Suite 8
  Cambridge
  MA
  02139
  Common
  02/22/2024
  119360
  2704646.63
  02/23/2024
  01/10/2024
  Ommer Chohan